Scientists predict that drugs will be available to treat Alzheimer’s within a decade.
“I think Alzheimer’s will be treatable. I hope by 2025 we will be able to slow the disease,” said Professor John Hardy of the Institute of Neurology at University College London. He added, “I think we will get to a situation where we will manage it in the way we manage diabetes now. I can see a day where dementia will not be a major issue”.
Alzheimer’s disease is caused by sticky amyloid plaques formation in the brain. This prevents neurons from communicating with each other.
Eli Lilly the pharmaceutical giants announced last summer that early trial result of solanezumab could prevent mental decline caused by Alzheimer’s.
Solanezumab is a monoclonal antibody. It binds amyloid in its early soluble form.
Experts have also predicted that the drug for Alzheimer’s could be prescribed like a daily pill to prevent the onset of it.
However, Simon Ridley, Director of Research at the Alzheimer’s Society emphasized, “we are not at the stage yet where we have a drug like a statin. The kind of drugs we are talking about at the moment would be very expensive infusion.”
Professor Morris, Professor of Neuroscience, University of Edinburgh commented that it was likely to be significant. He justified his statement by adding that the positive evidence showed by the new study for amyloid hypothesis, has been around for more than 20 years.
Meanwhile, the first effective medication that is widely available completely depends on two new treatments; these are now being tasted in clinical trials as reported by Express. Researchers are very hopeful about the treatments.
According to The Telegraph, in UK there are around 850,000 people who have dementia and within a span of less than 10 years the figure would jump up to 10 million.
The success of the research will bring hope and new zeal for life in many who are suffering from Alzheimer’s.